Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Infectious Disease Reports
Erschienen in: Current Infectious Disease Reports 6/2015

01.06.2015 | Healthcare Associated Infections (G Bearman and D Morgan, Section Editors)

The Pros, Cons, and Unknowns of Search and Destroy for Carbapenem-Resistant Enterobacteriaceae

verfasst von: Prashini Moodley, Andrew Whitelaw

Erschienen in: Current Infectious Disease Reports | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Antibiotic drug discovery has not kept pace with the development of microbial resistance to these agents. There are ever increasing reports where the causative agents of serious infections are multi-drug resistant and in some cases resistant to all known antibiotics. The emergence and spread of carbapenemase-producing Enterobacteriaceae has heightened awareness regarding antibiotic stewardship programs and infection prevention and control measures. There has been much controversy regarding the utility of the “search and destroy” strategy to prevent the spread of carbapenem-resistant Enterobacteriaceae. These controversies center on screening and management of carriers, including decontamination and isolation. It is however clear that a functional infection prevention and control program is fundamental to any strategy that serves to address the spread of microbes within a healthcare facility.
Literatur
1.
2.
Livermore DM. Antibiotic resistance in staphylococci. Int J Antimicrob Agents. 2000;16 Suppl 1:S3–10.CrossRefPubMed
3.
Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc. 1970;26:28–106.PubMed
4.
Kock R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, Kluytmans J, et al. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill: Bull Eur sur les Maladies Transmissibles = Eur Communicable Dis Bull. 2010;15(41):19688.
5.
Boyce JM, Suppl A. MRSA patients: proven methods to treat colonization and infection. J Hosp Infect. 2001;48:S9–14.CrossRefPubMed
6.
Boyce JM, Jackson MM, Pugliese G, Batt MD, Fleming D, Garner JS, et al. Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. The AHA technical panel on infections within hospitals. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am. 1994;15(2):105–15.CrossRef
7.
Ribeiro J, Boyce JM, Zancanaro PQ. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) among patients visiting the emergency room at a tertiary hospital in Brazil. Braz J Infect Dis: Off Publ Braz Soc Infect Dis. 2005;9(1):52–5.CrossRef
8.
Abecasis F, Kerr S, Sarginson RE, Silvestri L, de la Cal MA, Zandstra D, et al. Comment on: emergence of multidrug-resistant Gram-negative bacteria during selective decontamination of the digestive tract on an intensive care unit. J Antimicrob Chemother. 2007;60(2):445. author reply 446.CrossRefPubMed
9.
Petros A, Roos D, van Saene H, Taylor N, Rommes H, Silvestri L. Selective decontamination of the digestive tract may reduce perioperative risk in elective surgery. BMJ. 2011;343:d7536. author reply 7542.CrossRefPubMed
10.
Petros AJ, Silvestri L, Taylor N, Abecasis F, Damjanovic V, de la Cal MA, et al. Comment on: Selective decontamination of the oropharynx and the digestive tract, and antimicrobial resistance: a 4 year ecological study in 38 intensive care units in the Netherlands. J Antimicrob Chemother. 2014;69(3):860.CrossRefPubMed
11.
Silvestri L, de la Cal MA, Taylor N, van Saene HK, Parodi PC. Selective decontamination of the digestive tract in burn patients: an evidence-based maneuver that reduces mortality. J Burn Care Res: Off Publ Am Burn Assoc. 2010;31(2):372–3. author reply 374.CrossRef
12.
Silvestri L, Mannucci F, van Saene HK. Selective decontamination of the digestive tract: a life saver. J Hosp Infect. 2000;45(3):185–90.CrossRefPubMed
13.
Silvestri L, Petros AJ, Viviani M, Rommes JH, van Saene HK. Selective decontamination of the digestive tract and ventilator-associated pneumonia (part 1). Respir Care. 2006;51(1):67–9. author reply 70–62.PubMed
14.
Silvestri L, van Saene HK. Selective decontamination of the digestive tract does not increase resistance in critically ill patients: evidence from randomized controlled trials. Crit Care Med. 2006;34(7):2027–9. author reply 2029–2030.CrossRefPubMed
15.
Silvestri L, van Saene HK, de la Cal MA, Sarginson RE, Thomann C. Prevention of ventilator-associated pneumonia by selective decontamination of the digestive tract. Eur Respir J. 2008;32(1):241–3.CrossRefPubMed
16.
Silvestri L, van Saene HK, Milanese M, Gregori D, Gullo A. Selective decontamination of the digestive tract reduces bacterial bloodstream infection and mortality in critically ill patients. Systematic review of randomized, controlled trials. J Hosp Infect. 2007;65(3):187–203.CrossRefPubMed
17.
Silvestri L, van Saene HK, Petros AJ. Selective digestive tract decontamination in critically ill patients. Expert Opin Pharmacother. 2012;13(8):1113–29.CrossRefPubMed
18.
van Saene HK, Damjanovic V, Silvestri L, de la Cal MA, Zandstra DF. Selective decontamination of the digestive tract and ventilator-associated pneumonia (part 2). Respir Care. 2006;51(1):72–5. author reply 75.PubMed
19.
Petros A, Silvestri L, Booth R, Taylor N, van Saene H. Selective decontamination of the digestive tract in critically ill children: systematic review and meta-analysis. Pediatr Crit Care Med: J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2013;14(1):89–97.CrossRef
20.
Zandstra DF, Petros AJ, Silvestri L, de la Cal MA, Taylor N, Damjanovic V, et al. Selective decontamination of the digestive tract: selectivity is not required. Intensive Care Med. 2010;36(10):1783–4.CrossRefPubMedCentralPubMed
21.
Zandstra DF, Petros AJ, Taylor N, Silvestri L, de la Cal MA, van Saene HK. Withholding selective decontamination of the digestive tract from critically ill patients must now surely be ethically questionable given the vast evidence base. Crit Care. 2010;14(5):443.CrossRefPubMedCentralPubMed
22.
Petros AJ, Silvestri L, van Saene HK, Zandstra DF, de la Cal MA, Viviani M, et al. 2B or not 2B for selective decontamination of the digestive tract in the surviving sepsis campaign guidelines. Crit Care Med. 2013;41(11):e385–6.CrossRefPubMed
23.
Kollef MH, Micek ST. Rational use of antibiotics in the ICU: balancing stewardship and clinical outcomes. JAMA. 2014;312(14):1403–4.CrossRefPubMed
24.
Guh AY, Limbago BM, Kallen AJ. Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States. Expert Rev Anti-Infect Ther. 2014;12(5):565–80.CrossRefPubMed
25.
Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis: Off Publ Infect Dis Soc Am. 2011;53(1):60–7.CrossRef
26.
Williams RJ. Epidemiology of antibiotic resistance in gram-negative bacteria. J Hosp Infect. 1988;11(Suppl A):130–4.CrossRefPubMed
27.
Williams RJ, Heymann DL. Containment of antibiotic resistance. Science. 1998;279(5354):1153–4.CrossRefPubMed
28.
Williams RJ, Lindridge MA, Said AA, Livermore DM, Williams JD. National survey of antibiotic resistance in Pseudomonas aeruginosa. J Antimicrob Chemother. 1984;14(1):9–16.CrossRefPubMed
29.
Yang YJ, Livermore DM, Williams RJ. Chromosomal beta-lactamase expression and antibiotic resistance in Enterobacter cloacae. J Med Microbiol. 1988;25(3):227–33.CrossRefPubMed
30.
Kim NH, Han WD, Song KH, Seo HK, Shin MJ, Kim TS, et al. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance. Am J Infect Control. 2014;42(12):1270–3.CrossRefPubMed
31.
Barbarini D, Russello G, Brovarone F, Capatti C, Colla R, Perilli M, et al. Evaluation of carbapenem-resistant Enterobacteriaceae in an Italian setting: report from the trench. Infect Gen Evol: J Mol Epidemiol Evol Gen Infect Dis. 2014;30C:8–14.
32.
Muscarella LF. Risk of transmission of carbapenem-resistant Enterobacteriaceae and related “superbugs” during gastrointestinal endoscopy. World J Gastrointest Endosc. 2014;6(10):457–74.CrossRefPubMedCentralPubMed
33.
Zurawski RM. Carbapenem-resistant enterobacteriaceae: occult threat in the intensive care unit. Crit Care Nurse. 2014;34(5):44–52.CrossRefPubMed
34.
Rafailidis PI, Falagas ME. Options for treating carbapenem-resistant Enterobacteriaceae. Curr Opin Infect Dis. 2014;27(6):479–83.CrossRefPubMed
35.
Temkin E, Adler A, Lerner A, Carmeli Y. Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management. Ann N Y Acad Sci. 2014;1323:22–42.CrossRefPubMed
36.
Hsieh WS, Wang NY, Feng JA, Weng LC, Wu HH. Molecular surveillance and prevalence of carbapenem-resistant Enterobacteriaceae in northern Taiwan. J Antimicrob Chemother. 2014;69(10):2871–3.CrossRefPubMed
37.
Yamamoto M, Pop-Vicas AE. Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have? Crit Care. 2014;18(3):229.CrossRefPubMed
38.
Thaden JT, Lewis SS, Hazen KC, Huslage K, Fowler Jr VG, Moehring RW, et al. Rising rates of carbapenem-resistant Enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am. 2014;35(8):978–83.CrossRef
39.
Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis. 2014;20(7):1170–5.CrossRefPubMedCentralPubMed
40.
Palmore TN, Henderson DK. Carbapenem-resistant Enterobacteriaceae: a call for cultural change. Ann Intern Med. 2014;160(8):567–9.CrossRefPubMed
41.
Dirajlal-Fargo S, DeBiasi R, Campos J, Song X. Carbapenem-resistant Enterobacteriaceae in pediatric patients: epidemiology and risk factors. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am. 2014;35(4):447–9.CrossRef
42.
Drekonja DM, Beekmann SE, Elliott S, Mukundan D, Polenakovik H, Rosenthal ME, et al. Challenges in the management of infections due to carbapenem-resistant Enterobacteriaceae. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am. 2014;35(4):437–9.CrossRef
43.
Pisney LM, Barron MA, Kassner E, Havens D, Madinger NE. Carbapenem-resistant Enterobacteriaceae rectal screening during an outbreak of New Delhi metallo-beta-lactamase-producing Klebsiella pneumoniae at an acute care hospital. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am. 2014;35(4):434–6.CrossRef
44.
Fitzpatrick M, Zembower T, Malczynski M, Qi C, Bolon MK. Outcomes of an enhanced surveillance program for carbapenem-resistant Enterobacteriaceae. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am. 2014;35(4):419–22.CrossRef
45.
Landry J, Hurst H. The emerging threat from carbapenem-resistant enterobacteriaceae. NursWomens Health. 2013;17(6):519–24.
46.
Johnson K, Boucher HW. Editorial commentary: imminent challenges: carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancy. Clin Infect Dis: Off Publ Infect Dis Soc Am. 2014;58(9):1284–6.CrossRef
47.•
Schwaber MJ, Carmeli Y. An ongoing national intervention to contain the spread of carbapenem-resistant Enterobacteriaceae. Clin Infect Dis: Off Publ Infect Dis Soc Am. 2014;58(5):697–703. This study demonstrates the results that can be obtained through a nationally co-ordinated response to the challenge of CRE.CrossRef
48.
Kruse EB, Aurbach U, Wisplinghoff H. Carbapenem-resistant Enterobacteriaceae: laboratory detection and infection control practices. Curr Infect Dis Rep. 2013.
49.
Palmore TN, Henderson DK. Managing transmission of carbapenem-resistant Enterobacteriaceae in healthcare settings: a view from the trenches. Clin Infect Dis: Off Publ Infect Dis Soc Am. 2013;57(11):1593–9.CrossRef
50.
Arend LN, Pilonetto M, de Alencar Siebra C, Tuon FF. Phenotypic and molecular characterization of 942 carbapenem-resistant Enterobacteriaceae (CRE) in southern Brazil. J Infect Chemother: Off J Jpn Soc Chemother. 2014.
51.
Banach DB, Francois J, Blash S, Patel G, Jenkins SG, LaBombardi V, et al. Active surveillance for carbapenem-resistant Enterobacteriaceae using stool specimens submitted for testing for Clostridium difficile. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am. 2014;35(1):82–4.CrossRef
52.
Betts JW, Phee LM, Hornsey M, Woodford N, Wareham DW. In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae. Antimicrob Agents Chemother. 2014;58(6):3541–6.CrossRefPubMedCentralPubMed
53.
Birgy A, Bidet P, Genel N, Doit C, Decre D, Arlet G, et al. Phenotypic screening of carbapenemases and associated beta-lactamases in carbapenem-resistant Enterobacteriaceae. J Clin Microbiol. 2012;50(4):1295–302.CrossRefPubMedCentralPubMed
54.
Boyce JM, Havill NL. Comparison of BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR versus the CHROMagar MRSA assay for screening patients for the presence of MRSA strains. J Clin Microbiol. 2008;46(1):350–1.CrossRefPubMedCentralPubMed
55.
Havill NL, Boyce JM. Evaluation of a new selective medium, BD BBL CHROMagar MRSA II, for detection of methicillin-resistant Staphylococcus aureus in stool specimens. J Clin Microbiol. 2010;48(6):2228–30.CrossRefPubMedCentralPubMed
56.
Kazi M, Drego L, Nikam C, Ajbani K, Soman R, Shetty A, Rodrigues C. Molecular characterization of carbapenem-resistant Enterobacteriaceae at a tertiary care laboratory in Mumbai. Eur J Clin Microbiol Infect Dis: Off Publ Eur Soc Clin Microbiol. 2014.
57.
Kim J, Lee JY, Kim SI, Song W, Kim JS, Jung S, et al. Rates of fecal transmission of extended-spectrum beta-lactamase-producing and carbapenem-resistant Enterobacteriaceae among patients in intensive care units in Korea. Ann Lab Med. 2014;34(1):20–5.CrossRefPubMedCentralPubMed
58.
Lerner A, Romano J, Chmelnitsky I, Navon-Venezia S, Edgar R, Carmeli Y. Rectal swabs are suitable for quantifying the carriage load of KPC-producing carbapenem-resistant Enterobacteriaceae. Antimicrob Agents Chemother. 2013;57(3):1474–9.CrossRefPubMedCentralPubMed
59.
Michalska AD, Sacha PT, Ojdana D, Majewski P, Wieczorek P, Tryniszewska E. Carbapenem-resistant strains from the family Enterobacteriaceae isolated in the period 2006–2011 from clinical specimens of patients treated at the university hospital in northeastern Poland. Medycyna Doswiadczalna i Mikrobiologia. 2013;65(1):27–38.PubMed
60.
Pereira EC, Shaw KM, Vagnone PM, Harper JE, Kallen AJ, Limbago BM, et al. Thirty-day laboratory-based surveillance for carbapenem-resistant Enterobacteriaceae in the Minneapolis-St. Paul Metropolitan Area Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am. 2014;35(4):423–5.CrossRef
61.
Pollett S, Miller S, Hindler J, Uslan D, Carvalho M, Humphries RM. Phenotypic and molecular characteristics of carbapenem-resistant Enterobacteriaceae in a health care system in Los Angeles, California, from 2011 to 2013. J Clin Microbiol. 2014;52(11):4003–9.CrossRefPubMedCentralPubMed
62.
Samra Z, Bahar J, Madar-Shapiro L, Aziz N, Israel S, Bishara J. Evaluation of CHROMagar KPC for rapid detection of carbapenem-resistant Enterobacteriaceae. J Clin Microbiol. 2008;46(9):3110–1.CrossRefPubMedCentralPubMed
63.
Schechner V, Kotlovsky T, Tarabeia J, Kazma M, Schwartz D, Navon-Venezia S, et al. Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter. Infect Control Hosp Epidemiol: Official J Soc Hosp Epidemiol Am. 2011;32(5):497–503.CrossRef
64.
Villar HE, Baserni MN, Jugo MB. Faecal carriage of ESBL-producing Enterobacteriaceae and carbapenem-resistant Gram-negative bacilli in community settings. J Infect Dev Ctries. 2013;7(8):630–4.CrossRefPubMed
65.
Adler A, Navon-Venezia S, Moran-Gilad J, Marcos E, Schwartz D, Carmeli Y. Laboratory and clinical evaluation of screening agar plates for detection of carbapenem-resistant Enterobacteriaceae from surveillance rectal swabs. J Clin Microbiol. 2011;49(6):2239–42.CrossRefPubMedCentralPubMed
66.
Gazin M, Paasch F, Goossens H, Malhotra-Kumar S, Mosar WP, Teams SWS. Current trends in culture-based and molecular detection of extended-spectrum-beta-lactamase-harboring and carbapenem-resistant Enterobacteriaceae. J Clin Microbiol. 2012;50(4):1140–6.CrossRefPubMedCentralPubMed
67.
Lau AF, Wang H, Weingarten RA, Drake SK, Suffredini AF, Garfield MK, et al. A rapid matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for single-plasmid tracking in an outbreak of carbapenem-resistant Enterobacteriaceae. J Clin Microbiol. 2014;52(8):2804–12.CrossRefPubMedCentralPubMed
68.
Doyle D, Peirano G, Lascols C, Lloyd T, Church DL, Pitout JD. Laboratory detection of Enterobacteriaceae that produce carbapenemases. J Clin Microbiol. 2012;50(12):3877–80.CrossRefPubMedCentralPubMed
69.•
Poulou A, Voulgari E, Vrioni G, Xidopoulos G, Pliagkos A, Chatzipantazi V, et al. Imported Klebsiella pneumoniae carbapenemase-producing K. pneumoniae clones in a Greek hospital: impact of infection control measures for restraining their dissemination. J Clin Microbiol. 2012;50(8):2618–23. This study described the impact that can be made by a “package” of IPC practices, and re-emphasises the need for a multi-faceted approach.CrossRefPubMedCentralPubMed
70.
Kochar S ST, Sharma R, et al. Vital Signs: Carbapenem-resistant Enterobacteriaceae. In: Morbidity and mortality weekly report (MMWR). vol. 09. Atlanta: Centers for Disease Control and Prevention; 2013: 165–170.
71.
Landman D, Babu E, Shah N, Kelly P, Olawole O, Backer M, et al. Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration. J Antimicrob Chemother. 2012;67(6):1427–31.CrossRefPubMed
72.
Zimmerman FS, Assous MV, Bdolah-Abram T, Lachish T, Yinnon AM, Wiener-Well Y. Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge. Am J Infect Control. 2013;41(3):190–4.CrossRefPubMed
73.
Feldman N, Adler A, Molshatzki N, Navon-Venezia S, Khabra E, Cohen D, et al. Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent carriage. Clin Microbiol Infect: Off Publ Eur Soc Clin Microbiol Infect Dis. 2013;19(4):E190–6.CrossRef
74.
Savard P, Perl TM. Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose. Clin Microbiol Infect: Off Publ Eur Soc Clin Microbiol Infect Dis. 2014;20(9):854–61.CrossRef
75.
Drees M, Pineles L, Harris AD, Morgan DJ. Variation in definitions and isolation procedures for multidrug-resistant Gram-negative bacteria: a survey of the Society for Healthcare Epidemiology of America Research Network. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am. 2014;35(4):362–6.CrossRef
76.
Saidel-Odes L, Polachek H, Peled N, Riesenberg K, Schlaeffer F, Trabelsi Y, et al. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am. 2012;33(1):14–9.CrossRef
77.
Vandenbroucke-Grauls CM, Vandenbroucke JP. Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet. 1991;338(8771):859–62.CrossRefPubMed
78.
Liberati A, D’Amico R, Pifferi S, Torri V, Brazzi L, Parmelli E. Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database Syst Rev. 2009;4:CD000022.PubMed
79.
Silvestri L, van Saene HK, de la Cal MA, Zandstra DF, Viviani M, Peric M, et al. Surviving sepsis campaign needed consensus to exclude selective decontamination of the digestive tract. Crit Care Med. 2008;36(9):2716–7.CrossRefPubMed
80.
Schwaber MJ, Lev B, Israeli A, Solter E, Smollan G, Rubinovitch B, et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis: Off Publ Infect Dis Soc Am. 2011;52(7):848–55.CrossRef
81.
Carmeli Y, Akova M, Cornaglia G, Daikos GL, Garau J, Harbarth S, et al. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect: Off Publ Eur Soc Clin Microbiol Infect Dis. 2010;16(2):102–11.CrossRef
82.
Oren I, Sprecher H, Finkelstein R, Hadad S, Neuberger A, Hussein K, et al. Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: a prospective controlled trial. Am J Infect Control. 2013;41(12):1167–72.CrossRefPubMed
83.
Lubbert C, Faucheux S, Becker-Rux D, Laudi S, Durrbeck A, Busch T, et al. Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience. Int J Antimicrob Agents. 2013;42(6):565–70.CrossRefPubMed
84.
Kontopidou F, Giamarellou H, Katerelos P, Maragos A, Kioumis I, Trikka-Graphakos E, et al. Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options. Clin Microbiol Infect: Off Publ Eur Soc Clin Microbiol Infect Dis. 2014;20(2):O117–23.CrossRef
85.
Mathers AJ, Poulter M, Dirks D, Carroll J, Sifri CD, Hazen KC. Clinical microbiology costs for methods of active surveillance for Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Infect Control Hosp Epidemiol: Off J Soc Hosp Epidemiol Am. 2014;35(4):350–5.CrossRef
86.
O’Neil J. Review on antimicrobial resistance. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. In: Edited by resistance RoA, 01 edn. London, UK; 2014.
Metadaten
Titel
The Pros, Cons, and Unknowns of Search and Destroy for Carbapenem-Resistant Enterobacteriaceae
verfasst von
Prashini Moodley
Andrew Whitelaw
Publikationsdatum
01.06.2015
Verlag
Springer US
Erschienen in
Current Infectious Disease Reports / Ausgabe 6/2015
Print ISSN: 1523-3847
Elektronische ISSN: 1534-3146
DOI
https://doi.org/10.1007/s11908-015-0483-8

Weitere Artikel der Ausgabe 6/2015

Current Infectious Disease Reports 6/2015 Zur Ausgabe

Transplant and Oncology (M Ison and N Theodoropoulos, Section Editors)

Sepsis in the Severely Immunocompromised Patient

Genitourinary Infections (J Sobel, Section Editor)

The Role of PCR in the Diagnosis of Candida Vulvovaginitis—a New Gold Standard?

Intra-abdominal Infections, Hepatitis, and Gastroenteritis (T Steiner, Section Editor)

Epidemiology and Treatment of Trichomoniasis

Central Nervous System Infections (J Lyons, Section Editor)

HIV-associated Neurocognitive Disorders and Antiretroviral Therapy: Current Concepts and Controversies

Transplant and Oncology (M Ison and N Theodoropoulos, Section Editors)

The Swiss Transplant Cohort Study: Lessons from the First 6 Years

Genitourinary Infections (J Sobel, Section Editor)

Vulvovaginal Candidiasis in Pregnancy

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise